Closing remarks by Morimoto
FRONTEO has been holding study sessions with invited experts every month since April 2009. Following this initiative, FRONTEO plans to continue to provide information, recommendations and explanations to corporate personnel on strategic economic security measures.
In addition, through the expansion of the functions of Seizu Analysis, a network analysis system equipped with the AI Looca Cross, FRONTEO will support companies in discovering the information they want to know in a short period of time and in making decisions for strategic planning related to economic security.
For more information on FRONTEO's economic security solutions, please visit: https://osint.fronteousa.com/
■ About Nishimura & Asahi: https://www.nishimura.com/en
Nishimura & Asahi is Japan's largest international law firm, providing one-stop legal services of the highest caliber through the close cooperation of more than 700 domestic and international lawyers in 18 offices worldwide.
With a basic mission to realize a prosperous and fair society based on the rule of law, Nishimura & Asahi will contribute to the development of our clients and society by promising "Leading You Forward" to all parties concerned.
■ About FRONTEO URL: https://www.fronteo.com/en/
FRONTEO is a data analysis company that supports corporate businesses by extracting meaningful and important information from vast amounts of text data using KIBIT, conceptencoder, and Looca Cross, an AI engine developed in-house that specializes in natural language processing. Since its establishment in August 2003, the company has expanded its business globally to Japan, the U.S., Korea, and Taiwan, focusing on the legal tech business of e-discovery (electronic discovery) and digital forensic investigation to support international litigation. Based on the AI technology cultivated in the legal technology
business, we have expanded our business field to the life science field, business intelligence field, and OSINT since 2014, and by "turning text data into knowledge" using AI, we are contributing to solving various corporate issues such as drug discovery support, dementia diagnosis support, and financial, human resource, and sales support. The company was listed on the Tokyo Stock Exchange Mothers on June 26, 2007, and obtained a Type 1 Medical Device Manufacturing and Sales License (License Number: 13B1X10350) on January 13, 2021. Capital: 2,973,975 thousand yen (as of March 31, 2021).
※FRONTEO, KIBIT and conceptencoder are registered trademarks of FRONTEO in Japan.